CVE-2022-38351
HIGHCVSS 8.8/10EPSS 0.86%
Last modified
CVE-2022-38351 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.. EPSS estimates a 0.86% chance of exploitation in the next 30 days.
Description
A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.
Metrics
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Supremainc | Biostar 2 | 2.8.16 |
References
- https://nobugescapes.com/blog/privilege-escalation-from-user-operator-to-system-administrator/Exploit, Third Party Advisory
- https://nobugescapes.com/wp-content/uploads/2022/08/Part1.docxExploit, Third Party Advisory
- https://nobugescapes.com/blog/privilege-escalation-from-user-operator-to-system-administrator/Exploit, Third Party Advisory
- https://nobugescapes.com/wp-content/uploads/2022/08/Part1.docxExploit, Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2022-38351?
A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.
How severe is CVE-2022-38351?
CVE-2022-38351 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 0.86% probability of exploitation in the next 30 days.
How do I fix CVE-2022-38351?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2022-38351?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST